N@N

AEL, DYAX, ONXX, PFG, UMC, VRSN Are Seasonally Ripe To Go Up In the Next Five Weeks

October 31, 2012 / M2 PRESSWIRE / BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of American Equity Investment Life Holding Co (NYSE:AEL), Dyax Corp (NASDAQ:DYAX), ONYX PHARMACEUTICALS, INC. (NASDAQ:ONXX), Principal Financial Group Inc (NYSE:PFG), United Microelectronics Corp (NYSE:UMC), Verisign Inc (NASDAQ:VRSN) and each have a high seasonal probability to go Up in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at: http://www.squeezetrigger.com/services/strat/mh.php

The following stocks are expected to go Up:

  Symbol  Company                          Expected Return  Odds                 By The Following Date
  AEL     American Equity Investment Life Holding Co  6.81%            87.50% (7 of 8)      Monday, November 12th 2012
  DYAX    Dyax Corp                        7.55%            100.00% (12 of 12)   Friday, November 2nd 2012
  ONXX    ONYX PHARMACEUTICALS, INC.       10.14%           75.00% (9 of 12)     Wednesday, November 7th 2012
  PFG     Principal Financial Group Inc    5.03%            90.91% (10 of 11)    Tuesday, December 4th 2012
  UMC     United Microelectronics Corp     6.53%            75.00% (9 of 12)     Tuesday, November 13th 2012
  VRSN    Verisign Inc                     4.44%            91.67% (11 of 12)    Wednesday, November 7th 2012

American Equity Investment Life Holding Co (NYSE:AEL) - American Equity Investment Life Holding Company, through its subsidiaries, provides annuities and life insurance products in the United States and the District of Columbia. The company underwrites annuity and insurance products, as well as collects renewal premiums on certain accident and health insurance policies. Its annuity products include fixed index annuities and fixed rate annuities, as well as single premium immediate annuities. The companys insurance products comprise traditional ordinary and term, universal life, and other interest-sensitive life insurance products. It markets its products through a brokerage distribution network of approximately 50 national marketing organizations and approximately 41,000 independent agents. The company was founded in 1995 and is based in West Des Moines, Iowa..

Dyax Corp (NASDAQ:DYAX) - Dyax Corp., a biopharmaceutical company, engages in the discovery, development, and commercialization of biotherapeutics for unmet medical needs with an emphasis on inflammatory and oncology indications. The company utilizes its proprietary drug discovery technology, known as phage display, to identify antibody, small protein, and peptide compounds for clinical development. It commercializes its lead product candidate, DX-88, a recombinant small protein, under the KALBITOR (ecallantide) name for treatment of acute attacks of hereditary angioedema in patients 16 years of age and older. The company is also developing DX-88 for the reduction of blood loss during surgery in collaboration with Cubist Pharmaceuticals, Inc.; and for the treatment of retinal diseases in collaboration with Fovea Pharmaceuticals SA, as well as for the treatment of angiotensin converting enzyme inhibitor-induced angioedema and other angioedema indications. Its other discovery and development programs include DX-2240, an antibody that targets Tie-1 receptor on tumor blood vessels; and DX-2400 antibody, an inhibitor that inhibits matrix metalloproteinase 14 on tumor cells and tumor blood vessels. In addition, the company provides patent licenses to other biopharmaceutical and pharmaceutical companies to use its phage display patents, to discover and develop biologic compounds for use in specified fields; offers library licenses to use its phage display libraries in connection with their internal therapeutic development programs; and performs funded research for various collaborators. Further, it has co-development collaboration agreements with Athera Biotechnologies AB, Commonwealth Scientific and Industrial Research Organisation, Defiante Farmaceutica, S.A. and Syntonix Pharmaceuticals, Inc. Dyax Corp. was founded in 1989 and is headquartered in Cambridge, Massachusetts..

ONYX PHARMACEUTICALS, INC. (NASDAQ:ONXX) - Onyx Pharmaceuticals, Inc., a biopharmaceutical company, engages in developing therapies targeting the molecular mechanisms causing cancer in the United States and internationally. Its lead product includes Nexavar (sorafenib) tablets, a novel, oral multiple kinase inhibitor that targets proteins involved in tumor cell proliferation and angiogenesis. This product is being developed and marketed in collaboration with Bayer HealthCare Pharmaceuticals. Its developing products include Nexavar for the treatment of liver cancer, kidney cancer, non-small cell lung cancer, thyroid cancer, breast cancer, ovarian cancer, and colorectal cancer; and Carfilzomib for the treatment of multiple myeloma and solid tumor. The company also develops ONX 0801, a Phase 1 clinical stage product, under a development and license agreement with BTG International Limited; and ONX 0912, an oral proteasome inhibitor. In addition, it develops ONX 0914, a preclinical stage product for the treatment of autoimmune disorders, such as rheumatoid arthritis, inflammatory bowel disease, and lupus. In addition, Onyx Pharmaceuticals, through a development collaboration, option, and license agreement with S*BIO Pte Ltd, owns options to license the rights of ONX 0803 and ONX 0805. ONX 0803 is an orally available, potent, and selective inhibitor of JAK2; and ONX 0805 is a JAK2 inhibitor. Further, the company has a research and development collaboration agreement with Warner-Lambert Company to discover and commercialize small molecule drugs that restore the control of, or otherwise intervene in, the misregulated cell cycle in tumor cells. Onyx Pharmaceuticals, Inc. was founded in 1992 and is headquartered in Emeryville, California..

Principal Financial Group Inc (NYSE:PFG) - Principal Financial Group, Inc. provides retirement savings, investment, and insurance products and services worldwide. It operates in four segments: U.S. Asset Accumulation, Global Asset Management, International Asset Management and Accumulation, and Life and Health Insurance. The U.S. Asset Accumulation segment offers defined contribution pension plans, including 401(k) and 403(b) plans, defined benefit pension plans, nonqualified executive benefit plans, and employee stock ownership plan consulting services to small and medium-sized businesses; investment-only products, such as guaranteed investment contracts and funding agreements to large institutional clients; and the ability to accumulate funds for retirement and savings through mutual funds, individual annuities, and bank products to employees of businesses and other individuals. The Global Asset Management segment provides asset management services covering a range of asset classes, investment styles, and portfolio structures to its other segments and third-party institutional clients. This segment principally offers investment advisory services across three asset classes comprising equity investments, fixed income investments, and real estate investments. The International Asset Management and Accumulation segment offers long-term savings, retirement annuities, asset accumulation, mutual funds, life insurance, mortgage loans, and institutional asset management products and services. The Life and Health Insurance segment provides individual life insurance and group health insurance products and services, as well as other specialty benefits consisting of group dental and vision, group life, group long-term and short-term disability, and individual disability insurance services. The company was founded in 1879 and is based in Des Moines, Iowa..

United Microelectronics Corp (NYSE:UMC) - United Microelectronics Corporation, a semiconductor foundry, provides technology and manufacturing services for applications spanning various sectors of the integrated circuits industry in Asia. The company offers various foundry solutions, including IP and design methodology; process technologies; the manufacture of wafers; and test services and package solutions. It also provides various mask services, such as frame generation, data handling, and jobdeck view. The company was founded in 1980 and is headquartered in Hsinchu, Taiwan..

Verisign Inc (NASDAQ:VRSN) - VeriSign, Inc. provides Internet infrastructure services to various networks worldwide. It operates in two segments, Naming Services and Other Services. The Naming Services segment provides registry services and network intelligence and availability (NIA) Services. The registry services operate the authoritative directory of various .com, .net, .cc, .tv, .name domain names, as well as the back-end systems for various .jobs and .edu domain names. The NIA services provide infrastructure assurance to organizations, including VeriSign iDefense Security Intelligence Service (iDefense), Managed Domain Name System Services (Managed DNS), and Distributed Denial of Service (DDoS) mitigation. The Other Services segment comprises content portal services. VeriSign, Inc. was founded in 1995 and is headquartered in Dulles, Virginia..

SqueezeTrigger.com has built a massive database that collects, analyzes and publishes multiple proprietary trading strategies that predict price moves in stocks, commodities and currencies. The data has then been integrated into an automated trading platform which can be used to connect to a live online broker and automate your trading of each of the strategies highlighted. It is extremely powerful with lightening fast execution at a very low price. Both the trading software and SqueezeTrigger data feed are available at http://www.squeezetrigger.com

www.squeezetrigger.com monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements".

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO.

INVESTMENTS & TRADING

SqueezeTrigger -- 25 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

About SQUEEZETRIGGER.COM

WWW.SQUEEZETRIGGER.COM is a service designed to help bonafide shareholders of publicly traded US companies fight short selling. SqueezeTrigger.com has built a proprietary database that uses Threshold list feeds and short sale time and sale data from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short trades.

SQUEEZETRIGGER.COM has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted. The SqueezeTrigger database of nearly 2.5 billion short sale transactions goes back to January 1, 2005 and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like SqueezeTrigger.com to access the data.

The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each montha'a"s short transactions, SQUEEZETRIGGER.COM provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money and a short squeeze can begin.

All material herein was prepared by SQUEEZETRIGGER.COM, based upon information believed to be reliable. The information contained herein is not guaranteed by SQUEEZETRIGGER.COM to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion.

Occassionally companies pay $995.00 to purchase data for information provided in reports issued by BUYINS.NET, a company affiliated with SQUEEZETRIGGER.COM. The data service can be cancelled at any time. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. SQUEEZETRIGGER.COM is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. SQUEEZETRIGGER.COM will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.

SQUEEZETRIGGER.COM and SQUEEZETRIGGER are intended for use by stock market professionals. As a member, visitor, or user of any kind, you accept full responsibilities for your investment and trading actions. The contents of SQUEEZETRIGGER.COM, including but not limited to all implied or expressed views, opinions, teachings, data, graphs, opinions, or otherwise are not predictions, warranty, or endorsements of any kind. Please seek stock market advice from the proper securities professional, or investment advisor.

By visiting SQUEEZETRIGGER.COM or using any data or services, you agree to assume full responsibility for the decisions or actions that you undertake. Global Automated Trading Systems, LLC, its owner(s), operators, employees, partners, affiliates, advertisers, information providers and any other associated person or entity, shall under no circumstances be held liable to the user and/or any third party for loss or damages of any kind, including but not limited to trading losses, lost trading opportunity, direct, indirect, consequential, special, incidental, or punitive damages. As a user, you agree that any damages collected shall not exceed the amount paid to SQUEEZETRIGGER.COM and/or its owners. As a website user, you agree that any and all legal matters of any kind are to be reviewed and handled in their entirety within the State of California only. By using the services of this website, you are consenting to the terms as outlined, and forfeit all legal jurisdictions in any other State.

Past performance is not a guarantee of future outcomes. Any and all examples are hypothetical and should not be considered a guarantee or endorsement of such trading activity. SQUEEZETRIGGER.COM does not take responsibility for problems of any kind, including but not limited to issues with operations, data accuracy or completeness, contacting issues, technical issues, and timeliness. SQUEEZETRIGGER.COM places great integrity on the data collected and distributed. This information is deemed reliable, but not guaranteed. All information and data is provided "as is" without warranty or guarantee of any kind.

Please seek investment and/or trading advice, council, information or services from a securities professional. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and SQUEEZETRIGGER.COM undertakes no obligation to update such statements.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected", "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the SEC.

Contact: Thomas Ronk, CEO www.squeezetrigger.com +1-800-715-9999 Tom@squeezetrigger.com

SqueezeTrigger is a registered trademark, Reg. No. 3,120,641

Contributing Sources

---